CXL is a procedure that involves administering riboflavin and UVA in carefully selected parameters that strengthen the front layers of the cornea and avoid damage to the back of the eye.
We are each moms of incredible sons with Down syndrome who have also both been diagnosed with Keratoconus, one at age 25 and one at age 12. It progressed very rapidly in both our sons, going from mild to advanced in less than a year. CXL seemed like a miracle for us. This blog is to bring awareness of this wonderful treatment of Keratoconus and to encourage the FDA to "fast track" the approval of CXL.
